{
  "main_header": {
    "sid": 10039862,
    "name": "Sudeep Pharma",
    "stock_name": "Sudeep Pharma",
    "full_name": "Sudeep Pharma Ltd",
    "name_url": "stocks-analysis/sudeep-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "612.10",
    "chg": -3,
    "chgp": "-0.49%",
    "dir": -1,
    "prev_price": "615.10",
    "mcapval": "6,840.00 Cr",
    "mcap": "",
    "scripcode": 544619,
    "symbol": "SUDEEPPHRM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0QPI01025",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "23.37 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sudeep-pharma-10039862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039862",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sudeep-pharma-10039862"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation for Closure of Trading Window w.e.f. 1st April 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Mar-2026",
      "details": "Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per below details: Date & Time: 23rd March 2026 (12:00 pm onwards) Nature of Meeting: 1x1 / Group Meeting Place: Mumbai Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Kindly note that changes may happen due to exigencies on the part of Participants / Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "12-Feb-2026",
      "details": "Submission of Earnings Call Transcript for the earnings call held on 9th February 2026 to discuss the operational and financial performance of the Company for the third quarter and nine months ended on 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News